 | • レポートコード：MRC2203A215 • 出版社/出版日：Mordor Intelligence / 2022年2月28日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の凝固分析装置市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（分析装置、消耗品）分析、検査種類別（フィブリノーゲン検査、D-ダイマー検査、血小板機能検査、その他凝固検査）分析、技術別（光学技術、機械技術、電気化学技術、その他）分析、エンドユーザー別（病院、診断センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の凝固分析装置市場規模：製品別（分析装置、消耗品） ・世界の凝固分析装置市場規模：検査種類別（フィブリノーゲン検査、D-ダイマー検査、血小板機能検査、その他凝固検査） ・世界の凝固分析装置市場規模：技術別（光学技術、機械技術、電気化学技術、その他） ・世界の凝固分析装置市場規模：エンドユーザー別（病院、診断センター、その他） ・世界の凝固分析装置市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Nihon Kohden Corporation、F. Hoffmann-La Roche Ltd、Siemens Healthcare、…） ・市場機会・将来傾向 |
Coagulation Analyzers are used for detecting the presence of blood clots in the blood vessels. These analyzers measure coagulation pathway speed as well as thrombolin & thromboplastin levels in a few minutes. A coagulation analyzer system also has built-in quality control and security lockout protocols to ensure safe and secure use, as it is used on sensitive information about patient’s health.
The global coagulant analyzer market is driven by rise in the geriatric population, an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases, development of point of care (POC) coagulation testing, and the surge in laboratory automation. However, the high cost of fully automated coagulation analyzer and slow adoption of advanced hemostasis instruments in developing and underdeveloped economies are restraining the market growth.
Key Market Trends
D-Dimer Testing is Expected to Dominate the Market During the Forecast Period
D-dimer is one of the protein fragments produced when a blood clot gets dissolved in the body. It is usually undetectable or detectable at a very low amount unless the body is forming and breaking down blood clots. Then, its level in the blood can significantly rise. This test detects D-dimer in the blood.
It has been observed by the studies that an increased D-dimer and t-PA antigen levels are associated with Coronary Heart Disease (CHD) risk. As deaths due to Cardiovascular disease is expected to increase, the need for instruments used for analyzing D-Dimer is expected to increase, as this will help to understand CHD better. For instance, the World Health Organization has stated that cardiovascular diseases are the number one cause of deaths across the globe taking an estimated 17.9 million lives each year. Therefore, rising mortality associated with cardiovascular diseases is believed to augment the demand for D-Dimer testing.
North America is Expected to Dominate the Coagulation Analyzers Market
North America holds the largest share of the coagulation analyzers market which is majorly attributed to the well-established healthcare system acorss the countries such as United States and Canada and the large market of medical devices which is due to the presence of all international companies.
Asia-Pacific region is expected to witness rapid growth in the future which is due to the increasing adoption of technology and focus of the healthcare companies to enter the emerging economies such as India.
Competitive Landscape
There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. The competition is fierce due to the consolidated nature of the market with top companies reporting to occupy major share in the market. The key players in the market are adopting various strategic moves to sustain the intense competition.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Blood Disorders
4.2.2 Rising Geriatric Population Coupled with Increasing Prevalence of Chronic Diseases
4.2.3 Increasing Laboratory Automation
4.3 Market Restraints
4.3.1 Slow Adoption Rate in Underdeveloped Economies
4.3.2 High Cost of Test for Fully Automated Analyzers
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Analyzers
5.1.1.1 Clinical Laboratory Analyzers
5.1.1.2 Point of Care Analyzers
5.1.2 Consumables
5.2 By Test Type
5.2.1 Fibrinogen Testing
5.2.2 D-Dimer Testing
5.2.3 Platelet Function Tests
5.2.4 Other Coagulation Tests
5.3 By Technology
5.3.1 Optical Technology
5.3.2 Mechanical Technology
5.3.3 Electrochemical Technology
5.3.4 Others
5.4 By End User
5.4.1 Hospitals
5.4.2 Diagnostic Centers
5.4.3 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Nihon Kohden Corporation
6.1.2 F. Hoffmann-La Roche Ltd
6.1.3 Siemens Healthcare
6.1.4 DMS Imaging
6.1.5 Sysmex Corporation
6.1.6 Thermo Fisher Scientific Inc
6.1.7 Diagnostica Stago Sas
6.1.8 Helena Laboratories
6.1.9 Instrumentation Laboratory
6.1.10 Beckman Coulter Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS